Literature DB >> 23290182

Comparison of mesenchymal stem cells (osteoprogenitors) harvested from proximal humerus and distal femur during arthroscopic surgery.

Knut Beitzel1, Mary Beth R McCarthy, Mark P Cote, Thomas J S Durant, David M Chowaniec, Olga Solovyova, Ryan P Russell, Robert A Arciero, Augustus D Mazzocca.   

Abstract

PURPOSE: The aim of this study was to examine the relations between age, gender, and number of viable mesenchymal stem cells (MSCs) in concentrated bone marrow (BM) obtained from the proximal humerus and distal femur during arthroscopic surgery.
METHODS: BM was aspirated from either the proximal humerus (n = 55) or distal femur (n = 29) during arthroscopic surgery in 84 patients (51.3 ± 11.6 years). MSCs were obtained from fractionated bone marrow after a 5-minute spin at 1,500 rpm. Volume of BM and number of nucleated cells (NCs) were calculated, and samples were cultured for 6 days, after which point colony-forming units (CFUs) were quantified and fluorescence-activated cell sorting (FACS) analysis was performed. Simple linear regression was used to explore relations between age, gender, volume of aspirated BM, and MSCs per milliliter.
RESULTS: BM aspirations yielded a mean quantity of 22.6 ± 12.3 mL. After centrifugation, 30.0 ± 16.7 × 10(6) nucleated cells/mL of concentrated BM were harvested. The proximal humerus provided 38.7 ± 52.6 × 10(6), and the distal femur, 25.9 ± 14.3 × 10(6), for an overall 766.3 ± 545.3 MSCs/mL of concentrated BM (proximal humerus: 883.9 ± 577.6, distal femur: 551.3 ± 408.1). Values did not significantly differ by age, gender, or donor site.
CONCLUSIONS: Arthroscopic aspiration of bone marrow from the proximal humerus and distal femur is a reproducible technique and yields reliable concentrations of MSCs. The use of an intraoperative concentration method resulted in consistent amounts of MSCs in all clinically relevant age groups without a significant drop of the number of isolated MSCs. CLINICAL RELEVANCE: Human MSCs derived from concentrated bone marrow aspirate are a promising biological addition that may have practical use in the future of soft tissue augmentation. Arthroscopic techniques for bone marrow aspiration that do not require an additional surgical site for aspiration (e.g., iliac crest) or a second operative procedure may facilitate future use of MSCs in arthroscopic surgery.
Copyright © 2013 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23290182     DOI: 10.1016/j.arthro.2012.08.021

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  19 in total

Review 1.  Stem cell therapy in the management of shoulder rotator cuff disorders.

Authors:  Maria Valencia Mora; Miguel A Ruiz Ibán; Jorge Díaz Heredia; Raul Barco Laakso; Ricardo Cuéllar; Mariano García Arranz
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

Review 2.  Advances in biology and mechanics of rotator cuff repair.

Authors:  Olaf Lorbach; Mike H Baums; Tanja Kostuj; Stephan Pauly; Markus Scheibel; Andrew Carr; Nasim Zargar; Maristella F Saccomanno; Giuseppe Milano
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-01-09       Impact factor: 4.342

3.  Cell-based approaches for augmentation of tendon repair.

Authors:  Camila B Carballo; Amir Lebaschi; Scott A Rodeo
Journal:  Tech Shoulder Elb Surg       Date:  2017-09-01

4.  Assessment of Multipotent Mesenchymal Stromal Cells in Bone Marrow Aspirate From Human Calcaneus.

Authors:  Chunmei Li; Cory D Kilpatrick; Shannon Smith; Dean L Glettig; Douglas J Glod; Jason Mallette; Michael R Strunk; Jerry Chang; Siddhesh R Angle; David L Kaplan
Journal:  J Foot Ankle Surg       Date:  2017 Jan - Feb       Impact factor: 1.286

5.  Expression of inflammatory cytokines in mesenchymal stem cells derived from proximal humerus fractures.

Authors:  Magda Massae Hata Viveiros; Márcio Eduardo de Melo Viveiros; Márcia Guimarães Silva; Ramon Kaneno; Natália Porfírio Avelino; Cláudia Aparecida Rainho; Silvana Artioli Schellini
Journal:  Stem Cell Investig       Date:  2022-04-12

Review 6.  Evaluating strategies and outcomes following rotator cuff tears.

Authors:  Kelms Amoo-Achampong; Michael K Krill; Derrick Acheampong; Benedict U Nwachukwu; Frank McCormick
Journal:  Shoulder Elbow       Date:  2018-04-26

7.  Microcarrier Screening and Evaluation for Dynamic Expansion of Human Periosteum-Derived Progenitor Cells in a Xenogeneic Free Medium.

Authors:  Kathleen Van Beylen; Ioannis Papantoniou; Jean-Marie Aerts
Journal:  Front Bioeng Biotechnol       Date:  2021-05-24

Review 8.  Regenerative medicine in rotator cuff injuries.

Authors:  Pietro Randelli; Filippo Randelli; Vincenza Ragone; Alessandra Menon; Riccardo D'Ambrosi; Davide Cucchi; Paolo Cabitza; Giuseppe Banfi
Journal:  Biomed Res Int       Date:  2014-08-13       Impact factor: 3.411

9.  The Role of Platelet Rich Plasma (PRP) and Other Biologics for Rotator Cuff Repair.

Authors:  Joshua A Greenspoon; Samuel G Moulton; Peter J Millett; Maximilian Petri
Journal:  Open Orthop J       Date:  2016-07-21

10.  Biologic Treatments for Sports Injuries II Think Tank-Current Concepts, Future Research, and Barriers to Advancement, Part 2: Rotator Cuff.

Authors:  Iain R Murray; Robert F LaPrade; Volker Musahl; Andrew G Geeslin; Jason P Zlotnicki; Barton J Mann; Frank A Petrigliano
Journal:  Orthop J Sports Med       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.